The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer
Cancers · 08.06.2023 · 15 (12) · 3110
DOI: 10.3390/cancers15123110 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 08.06.2023. Verfasst von Saheed Oluwasina Oseni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Florida Atlantic University, Boca Raton, FL 33431, USA. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 302 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mary N. Porter Cancer Research Fund of The Community Foundation of Broward (G.B.F.), James and Esther King Biomedical Research Program.
Abstract (Originalsprache)
Chronic inflammation is now recognized as one of the major risk factors and molecular hallmarks of chronic prostatitis, benign prostatic hyperplasia (BPH), and prostate tumorigenesis. However, the molecular mechanisms by which chronic inflammation signaling contributes to the pathogenesis of these prostate diseases are poorly understood. Previous efforts to therapeutically target the upstream (e.g., TLRs and IL1-Rs) and downstream (e.g., NF-κB subunits and cytokines) inflammatory signaling molecules in people with these conditions have been clinically ambiguous and unsatisfactory, hence fostering the recent paradigm shift towards unraveling and understanding the functional roles and clinical significance of the novel and relatively underexplored inflammatory molecules and pathways that could become potential therapeutic targets in managing prostatic diseases. In this review article, we exclusively discuss the causal and molecular drivers of prostatitis, BPH, and prostate tumorigenesis, as well as the potential impacts of microbiome dysbiosis and chronic inflammation in promoting prostate pathologies. We specifically focus on the importance of some of the underexplored druggable inflammatory molecules, by discussing how their aberrant signaling could promote prostate cancer (PCa) stemness, neuroendocrine differentiation, castration resistance, metabolic reprogramming, and immunosuppression. The potential contribution of the IL1R-TLR-IRAK-NF-κBs signaling molecules and NLR/inflammasomes in prostate pathologies, as well as the prospective benefits of selectively targeting the midstream molecules in the various inflammatory cascades, are also discussed. Though this review concentrates more on PCa, we envision that the information could be applied to other prostate diseases. In conclusion, we have underlined the molecular mechanisms and signaling pathways that may need to be targeted and/or further investigated to better understand the association between chronic inflammation and prostate diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological Sciences, Florida Atlantic University, Boca Raton, FL 33431, USA.
- H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
- Department of Computer and Electrical Engineering, Florida Atlantic University, Boca Raton, FL 33431, USA.
- Department of Chemistry & Biochemistry, and I-HEALTH, Florida Atlantic University, Boca Raton, FL 33431, USA.
ORCID-Profile: Saheed Oluwasina Oseni, Waseem Asghar, Gregg B Fields, Nwadiuto Esiobu, James Kumi-Diaka
Förderung
- Mary N. Porter Cancer Research Fund of The Community Foundation of Broward (G.B.F.)
- James and Esther King Biomedical Research Program
Zitieren
APA
Oseni, S. O., Naar, C., Pavlović, M., Asghar, W., Hartmann, J. X., Fields, G. B., Esiobu, N., & Kumi-Diaka, J. (2023). The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer. Cancers, 15(12), 3110. https://doi.org/10.3390/cancers15123110
Vancouver
Oseni SO, Naar C, Pavlović M, Asghar W, Hartmann JX, Fields GB, et al. The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer. Cancers. 2023;15(12):3110. doi:10.3390/cancers15123110
BibTeX
@article{Oseni2023,
author = {Oseni, Saheed Oluwasina and Naar, Corey and Pavlović, Mirjana and Asghar, Waseem and Hartmann, James X and Fields, Gregg B and Esiobu, Nwadiuto and Kumi-Diaka, James},
title = {The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer},
journal = {Cancers},
year = {2023},
volume = {15},
number = {12},
pages = {3110},
doi = {10.3390/cancers15123110}
}
EUVIMED